Related Experiment Videos
Chronic sinusitis with nasal polyps: staphylococcal exotoxin immunoglobulin E and cellular inflammation
David B Conley1, Anju Tripathi, Anne M Ditto
1Department of Otolaryngology--Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
American Journal of Rhinology
|December 14, 2004
Summary
Chronic sinusitis with nasal polyposis (CS/NP) patients frequently show immunoglobulin E (IgE) responses to Staphylococcus aureus exotoxins, unlike healthy controls. This suggests a potential role for these toxins in CS/NP pathogenesis.
Area of Science:
- Immunology
- Otolaryngology
- Microbiology
Background:
- The exact cause of chronic sinusitis with nasal polyposis (CS/NP) is unknown.
- Staphylococcus aureus is often found in CS/NP patients, but its role is unclear.
- Exotoxins secreted by S. aureus may trigger inflammatory changes in CS/NP, similar to atopic dermatitis.
Purpose of the Study:
- To investigate the hypothesis that Staphylococcus aureus exotoxins contribute to the immunopathology of CS/NP.
- To assess the systemic IgE response to S. aureus exotoxins in CS/NP patients.
Main Methods:
- Serum samples from CS/NP patients and controls were analyzed for IgE levels against S. aureus exotoxins (SEA, SEB, TSST-1) using ELISA.
- Nasal polyp tissues were examined for eosinophilia and lymphocyte presence.
- Correlated IgE levels with tissue inflammation markers.
Main Results:
- 50% of CS/NP patients had detectable IgE to S. aureus exotoxins, compared to 0% in controls (p=0.031).
- A trend towards higher polyp eosinophil counts was observed in patients with exotoxin-specific IgE, though not statistically significant.
- No significant correlation was found between IgE levels and lymphocyte or mononuclear cell counts.
Conclusions:
- A significant proportion of CS/NP patients exhibit a systemic IgE response to S. aureus exotoxins.
- These findings support the potential involvement of Staphylococcus toxins in CS/NP, mirroring their role in other conditions.
- Further research is needed to confirm a local superantigen response in the nasal mucosa of CS/NP patients.